First Wave BioPharma, Inc. Stock Forecast

Stronger technical forecast for First Wave BioPharma, Inc. stock price after Monday trading.
(Updated on May 20, 2024)

FWBI Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The First Wave BioPharma, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $3.08. On a fall, the stock will find some support from the short-term average at $2.93. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Friday, May 17, 2024, and so far it has fallen 0%. Further fall is indicated until a new bottom pivot has been found. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for First Wave BioPharma, Inc. stock

First Wave BioPharma, Inc. finds support from accumulated volume at $2.91 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 5.03%

Our recommended stop-loss: $2.85 (-3.72%) (This stock has low daily movements and this gives low risk. There is a sell signal from a pivot top found 2 days ago.)

Trading Expectations (FWBI) For The Upcoming Trading Day Of Tuesday 21st

For the upcoming trading day on Tuesday, 21st we expect First Wave BioPharma, Inc. to open at $2.96, and during the day (based on 14 day Average True Range), to move between $2.70 and $3.22, which gives a possible trading interval of +/-$0.261 (+/-8.81%) up or down from last closing price. If First Wave BioPharma, Inc. takes out the full calculated possible swing range there will be an estimated 17.62% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.91 (1.69%) than the resistance at $3.02 (2.03%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is First Wave BioPharma, Inc. stock A Buy?

First Wave BioPharma, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

Current score: 0.000 Hold/Accumulate Upgraded

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Opening Price for First Wave BioPharma, Inc. of Tuesday, May 21, 2024

The predicted opening price is based on yesterday's movements between high, low, and closing price.